|
Mr. Hamilton is a founder of Salix Pharmaceuticals, Inc., and served as Chairman of the Board, President, and Chief Executive Officer from the company's inception through November 1999. He remained Executive Chairman of the Board until June 2002. Prior to founding Salix, Mr. Hamilton was Manager of Business Development for California Biotechnology, Inc. (now Scios, Inc.), responsible for the commercial aspects of several of the company's development projects, including human lung surfactant, drug delivery systems, genetic marker diagnosis, and growth factors. He was also responsible for establishing strategic relationships with the Japanese pharmaceutical industry. Before joining California Biotechnology, Inc., Mr. Hamilton was Director of Strategic Planning and Business Development for SmithKline Diagnostics, then a division of SmithKline Beckman, where he also held positions in market research and marketing information services. Mr. Hamilton received a B.A. in sociology from California State University, Long Beach. In 1998, Mr. Hamilton was named "Man of the Year" by the Crohn's and Colitis Foundation of America, Bay Area chapter. | 